Q
Qpex Biopharma
Developing innovative products through novel strategies for infectious diseases
About Qpex Biopharma
Qpex Biopharma is a biotechnology company based in San Diego, specializing in the discovery, development, and regulatory approval of anti-infective medicines. The company focuses on creating new antibiotics to combat antimicrobial resistance, a growing global health threat. Qpex Biopharma collaborates with public-private partnerships to accelerate the development and impact of its products. The company serves healthcare providers and patients, particularly those affected by drug-resistant bacterial infections. Operating in the pharmaceutical and biotechnology markets, Qpex Biopharma generates revenue through the development and commercialization of its innovative antibiotic therapies. By leveraging its deep expertise and novel strategies, the company aims to make significant, sustainable improvements in patient care across both inpatient and outpatient settings.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANTOther financing | May 2024 | $10M | — | HHS Administration for Strategic Preparedness and Response | ↗ |
| ACQUISITIONOther financing | Jun 2023 | $0 | — | Shionogi | ↗ |
Growth signals
Latest recorded traffic for Qpex Biopharma is 2.9K monthly website visits, down 31% over the last three months. Qpex Biopharma's team grew 5.9% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Qpex Biopharma in the San Diego ecosystem
The Qpex Biopharma office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
HHS Administration for Strategic Preparedness and Response
Series A4 investors entered at this stage
Adams Street Partners
Hatteras Venture Partners- LCLYZZ Capital
NEA
Other known investors1 additional known investor
Shionogi
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Qpex Biopharma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Qpex Biopharma’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









